| View |
|
DR-XY49189
|
Sitagliptin (as phosphate monohydrate)
|
Jentin
|
50 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug [Dipeptidyl Peptidase 4
(DPP-4) Inhibitor]
|
The Searle Company Limited
|
Pakistan
|
Initial
|
13 September 2024
|
13 September 2029
|
| View |
|
DR-XY49190
|
Sitagliptin (as phosphate monohydrate)
|
Jentin
|
100 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug [Dipeptidyl Peptidase 4
(DPP-4) Inhibitor]
|
The Searle Company Limited
|
Pakistan
|
Initial
|
13 September 2024
|
13 September 2029
|
| View |
|
DRP-14629
|
Atosiban (as acetate)
|
Tracsiban
|
7.5 mg (equivalent to 7.953 mg Atosiban Acetate)/mL
|
Solution for Injection (IM/IV/SC)
|
Other Gynecologicals
|
Hanlim Pharm. Co., Ltd.
|
Korea
|
Initial
|
11 September 2024
|
11 September 2029
|
| View |
|
DRP-15769
|
Azithromycin (as dihydrate)
|
Azitritec
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Sunrise International Labs Limited
|
India
|
Initial
|
12 September 2024
|
12 September 2029
|
| View |
|
DR-XY49206
|
Diclofenac (as Sodium)
|
Alisakit Plaster
|
15 mg
|
Plaster
|
Non-steroidal Anti-Inflammatory Drug (NSAID)
|
Sinil Pharmaceutical Co., Ltd.
|
Korea
|
Monitored Release (MR)
|
13 September 2024
|
13 September 2029
|
| View |
|
DRP-15783
|
Nitroglycerine
|
Nitroshot
|
1 mg/mL (10 mg/10 mL)
|
Solution for Injection (IV)
|
Anti-angina
|
Farbe Firma Pvt. Ltd.
|
India
|
Initial
|
13 September 2024
|
13 September 2029
|
| View |
|
DR-XY49205
|
Pioglitazone (as hydrochloride) + Glimepiride
|
Asenza Plus
|
30 mg/ 2 mg
|
Tablet
|
Blood Glucose Lowering Drugs Combination
|
Ajanta Pharma Limited
|
India
|
Initial
|
12 September 2024
|
12 September 2029
|
| View |
|
DR-XY49204
|
Pioglitazone (as hydrochloride) + Glimepiride
|
Asenza Plus
|
15 mg/2 mg
|
Tablet
|
Blood Glucose Lowering Drugs Combination
|
Ajanta Pharma Limited
|
India
|
Initial
|
12 September 2024
|
12 September 2029
|
| View |
|
DRP-15788
|
Telmisartan
|
Telminow 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Cubit Lifesciences LLP
|
India
|
Initial
|
12 September 2024
|
12 September 2029
|
| View |
|
DRP-15807
|
Diosmin + Hesperidin
|
Osper 1000
|
900 mg/100 mg
|
Film-coated Tablet
|
Vasoprotective
|
Flourish Pharma
|
India
|
Initial [OTC]
|
16 September 2024
|
16 September 2029
|
| View |
|
DRP-15808
|
Diosmin + Hesperidin
|
Osper 500
|
450 mg/50 mg
|
Film-coated Tablet
|
Vasoprotective
|
Flourish Pharma
|
India
|
Initial [OTC]
|
16 September 2024
|
16 September 2029
|
| View |
|
DRP-15805
|
Ascorbic Acid + Zinc+ Cholecalciferol (Vitamin D3)
|
Lifecorzin D3
|
500 mg (equivalent to 562.43 Sodium Ascorbate)/15 mg (equivalent to 105 mg Zinc gluconate)/1000 IU
|
Capsule
|
Vitamin/Mineral
|
Flourish Pharma
|
India
|
Initial [OTC]
|
16 September 2024
|
16 September 2029
|
| View |
|
DRP-15822
|
Donepezil hydrochloride
|
Onzepil 5
|
5 mg
|
Film-Coated Tablet
|
Anti-Dementia (Anticholinesterase)
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
Initial
|
18 September 2024
|
18 September 2029
|
| View |
|
BR-1488
|
Respiratory Syncytial Virus Vaccine (bivalent, recombinant)
|
Abrysvo
|
Formulation:
After reconstitution, 0.5mL (one dose) contains:
RSV subgroup A stabilized prefusion F antigen 1.2
60 micrograms RSV subgroup B stabilized prefusion F antigen 1.2
60 micrograms
(RSV antigens)
glycoprotein F stabilized in the prefusion conformation
produced in Chinese Hamster Ovary cells by recombinant DNA technology.
|
Lyophilized Powder and Solvent for
Solution for Intramuscular Injection
|
Vaccine
|
Pfizer Manufacturing Belgium NV
|
Belgium
|
Monitored Release
|
18 September 2024
|
18 September 2029
|
| View |
|
BR-1489
|
Respiratory Syncytial Virus Vaccine (Bivalent, Recombinant)
|
Abrysvo
|
Formulation:
After reconstitution, 0.5mL (one dose) contains:
RSV subgroup A stabilized prefusion F antigen 1.2
60 micrograms
RSV subgroup B stabilized prefusion F antigen 1.2
60 micrograms (RSV antigens)
1 glycoprotein F stabilized in the prefusion conformation
2 produced in Chinese Hamster Ovary cells by recombinant DNA technology.
|
Lyophilized Powder and Solvent for
Solution for Intramuscular Injection
|
Vaccine
|
Pfizer Manufacturing Belgium NV
|
Belgium
|
Monitored Release
|
18 September 2024
|
18 September 2029
|
| View |
|
DRP-15824
|
Linagliptin
|
Lineptin
|
5 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
Initial
|
18 September 2024
|
18 September 2029
|
| View |
|
DRP-15823
|
Lacosamide
|
Philsamide-100
|
100 mg
|
Film-Coated Tablet
|
Antiepileptic
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
Initial
|
18 September 2024
|
18 September 2029
|
| View |
|
DRP-15796
|
Betahistine Hydrochloride
|
Betazar
|
16mg
|
Tablet
|
Antivertigo Preparation.
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Initial
|
18 September 2024
|
18 September 2029
|
| View |
|
DRP-15810
|
Cefalexin (as monohydrate)
|
Cefathix
|
500 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
Medico Remedies Limited
|
India
|
Initial
|
17 September 2024
|
17 September 2026
|
| View |
|
DRP-15812
|
Dexketoprofen (as Trometamol)
|
None
|
25 mg
|
Tablet
|
Non-steroidal Anti-inflammatory/Anti-rheumatic
(Propionic Acid Derivative)
|
Novagen Healthcare Private Limited
|
India
|
Initial
|
17 September 2024
|
17 September 2029
|